Thymmune Therapeutics | LinkedIn (original) (raw)

About us

Thymmune is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease. The company's cutting-edge approach in iPSC-thymic cell manufacturing can generate off-the-shelf cells at scale. The company is developing a pipeline of therapies to treat immunodeficiencies, transplant related, and autoimmune diseases. Thymmune is based in Cambridge, MA. For more information, visit www.thymmune.com.

Industry

Biotechnology

Company size

11-50 employees

Headquarters

Cambridge, Massachusetts

Type

Privately Held

Locations

Employees at Thymmune Therapeutics

Updates

Join now to see what you are missing

Join now

Similar pages

Browse jobs

Funding